Ar. Conant et al., CHARACTERIZATION OF THE P2 RECEPTORS ON THE HUMAN UMBILICAL VEIN ENDOTHELIAL-CELL LINE ECV304, British Journal of Pharmacology, 125(2), 1998, pp. 357-364
1 To characterize the P2 receptors present on the human umbilical vein
endothelial-derived cell line, ECV304, cytosolic Ca2+, ([Ca2+](c)), r
esponses were recorded in single cells and in cell suspensions to a se
ries of nucleotides and nucleotide agonists. 2 Concentration response
curves were obtained in fura-2-loaded ECV304 cell suspensions, with EC
50 values of 4.2 mu M for ATP, 2.5 mu M for UTP and 14 mu M for adenos
ine-5'-O-(3-thio)triphosphate (ATP gamma S). EC50 values for 2-methylt
hioATP, ADP, adenosine-5'-O-(2-thio)diphosphate (ADP beta S) and AMP w
ere 0.5 mu M, 3.5 mu M, 15 mu M and 4.7 mu M respectively, but maximal
[Ca2+](c) responses were less than those produced by a maximal additi
on of ATP/UTP. ECV304 cells were unresponsive to UDP and beta,gamma,me
thyleneATP. 3 Cross-desensitization studies on ECV304 cells suggested
that ATP and UTP recognized the same receptor. However, ADP recognized
a receptor distinct from the UTP-sensitive receptor and AMP recognize
d a third distinct receptor. 4 ECV304 [Ca2+](c) responses to 2-methylt
hioATP were inhibited in the presence of 30 mu M pyridoxalphosphate-6-
azophenyl-2',4'-dis acid (PPADS), whereas [Ca2+](c) responses to UTP w
ere unaffected by this treatment. 5 ECV304 cells responded to the diad
enosine polyphosphate Ap,A with rises in [Ca2+](c). Apparent responses
to Ap(4)A, Ap(5)A and Ap(6)A, were shown to be due to a minor nucleot
ide contaminant that could be removed by pre-treatment of the diadenos
ine samples with either alkaline phosphatase or apyrase. 6 ECV304 cell
s display a pharmacology consistent with the presence of at least two
P2 receptors; a P2Y(2) receptor insensitive to the diadenosine polypho
sphates and a P2Y(1) receptor sensitive to Ap(3)A. In addition, ECV304
cells respond to AMP with increases in [Ca2+](c) via an as yet unchar
acterized receptor.